264 related articles for article (PubMed ID: 24345905)
1. Effect of dexmedetomidine on lung ischemia‑reperfusion injury.
Jiang L; Li L; Shen J; Qi Z; Guo L
Mol Med Rep; 2014 Feb; 9(2):419-26. PubMed ID: 24345905
[TBL] [Abstract][Full Text] [Related]
2. Dexmedetomidine protects against lung injury induced by limb ischemia-reperfusion via the TLR4/MyD88/NF-κB pathway.
Xue BB; Chen BH; Tang YN; Weng CW; Lin LN
Kaohsiung J Med Sci; 2019 Nov; 35(11):672-678. PubMed ID: 31373750
[TBL] [Abstract][Full Text] [Related]
3. The effect of dexmedetomidine on inflammatory response of septic rats.
Zhang J; Wang Z; Wang Y; Zhou G; Li H
BMC Anesthesiol; 2015 May; 15():68. PubMed ID: 25929655
[TBL] [Abstract][Full Text] [Related]
4. Dexmedetomidine preconditioning may attenuate myocardial ischemia/reperfusion injury by down-regulating the HMGB1-TLR4-MyD88-NF-кB signaling pathway.
Zhang JJ; Peng K; Zhang J; Meng XW; Ji FH
PLoS One; 2017; 12(2):e0172006. PubMed ID: 28222157
[TBL] [Abstract][Full Text] [Related]
5. Dexmedetomidine attenuates remote lung injury induced by renal ischemia-reperfusion in mice.
Gu J; Chen J; Xia P; Tao G; Zhao H; Ma D
Acta Anaesthesiol Scand; 2011 Nov; 55(10):1272-8. PubMed ID: 22092133
[TBL] [Abstract][Full Text] [Related]
6. Dexmedetomidine Resists Intestinal Ischemia-Reperfusion Injury by Inhibiting TLR4/MyD88/NF-κB Signaling.
Yang J; Wu Y; Xu Y; Jia J; Xi W; Deng H; Tu W
J Surg Res; 2021 Apr; 260():350-358. PubMed ID: 33383282
[TBL] [Abstract][Full Text] [Related]
7. Dexmedetomidine Post-Conditioning Alleviates Cerebral Ischemia-Reperfusion Injury in Rats by Inhibiting High Mobility Group Protein B1 Group (HMGB1)/Toll-Like Receptor 4 (TLR4)/Nuclear Factor kappa B (NF-κB) Signaling Pathway.
Zhai Y; Zhu Y; Liu J; Xie K; Yu J; Yu L; Deng H
Med Sci Monit; 2020 Jan; 26():e918617. PubMed ID: 31912804
[TBL] [Abstract][Full Text] [Related]
8. Dexmedetomidine alleviates lung ischemia-reperfusion injury in rats by activating PI3K/Akt pathway.
Liang S; Wang Y; Liu Y
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):370-377. PubMed ID: 30657579
[TBL] [Abstract][Full Text] [Related]
9. Dexmedetomidine alleviates non-ventilation associated lung injury via modulating immunology phenotypes of macrophages.
Shen Q; Xu G; Liu J; Wang L; Zhou Y; Yu Y; Lv C; Liu X
Life Sci; 2020 Oct; 259():118249. PubMed ID: 32798558
[TBL] [Abstract][Full Text] [Related]
10. Dexmedetomidine reduces ventilator-induced lung injury (VILI) by inhibiting Toll-like receptor 4 (TLR4)/nuclear factor (NF)-κB signaling pathway.
Chen H; Sun X; Yang X; Hou Y; Yu X; Wang Y; Wu J; Liu D; Wang H; Yu J; Yi W
Bosn J Basic Med Sci; 2018 May; 18(2):162-169. PubMed ID: 29510084
[TBL] [Abstract][Full Text] [Related]
11. [Effects of Dexmedetomidine on the levels of proinflammatory mediators IL-1βand TNF-α in pulmonary ischemia/reperfusion injury rats and the mechanisms].
Xiang BQ; He JB; Gao H; Luo ZY; Dai YY; Wang WT
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2017 May; 33(5):415-419. PubMed ID: 29926585
[TBL] [Abstract][Full Text] [Related]
12. Dexmedetomidine attenuates cerebral ischemia-reperfusion injury in rats by inhibiting the JNK pathway.
Zhao B; Li D; Zhang S; He L; Ai Y
Ann Palliat Med; 2021 Jun; 10(6):6768-6778. PubMed ID: 34237977
[TBL] [Abstract][Full Text] [Related]
13. Dexmedetomidine attenuates lipopolysaccharide induced acute lung injury in rats by inhibition of caveolin-1 downstream signaling.
Liu J; Huang X; Hu S; He H; Meng Z
Biomed Pharmacother; 2019 Oct; 118():109314. PubMed ID: 31545263
[TBL] [Abstract][Full Text] [Related]
14. [Dexmedetomidine preconditioning alleviates acute lung injury induced by intestinal ischemia-reperfusion in rats by inhibiting NLRP3 inflammasome activation].
Han B; Chen M; Yang C; Li X
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Dec; 41(12):1857-1863. PubMed ID: 35012919
[TBL] [Abstract][Full Text] [Related]
15. TLR4-HMGB1-, MyD88- and TRIF-dependent signaling in mouse intestinal ischemia/reperfusion injury.
Wang J; He GZ; Wang YK; Zhu QK; Chen W; Guo T
World J Gastroenterol; 2015 Jul; 21(27):8314-25. PubMed ID: 26217083
[TBL] [Abstract][Full Text] [Related]
16. [Dexmedetomidine prevents inflammatory responses in injured rat lung tissues induced by ischemia/reperfusion through inhibition of TLR4 expression].
He JB; Song D; Luo ZY; Zhang CC; Ying L; Wang Y; Wang WT
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2016 Apr; 32(4):356-360. PubMed ID: 29931961
[TBL] [Abstract][Full Text] [Related]
17. Dexmedetomidine Protects Rat Liver against Ischemia-Reperfusion Injury Partly by the α2A-Adrenoceptor Subtype and the Mechanism Is Associated with the TLR4/NF-κB Pathway.
Wang Y; Wu S; Yu X; Zhou S; Ge M; Chi X; Cai J
Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347929
[TBL] [Abstract][Full Text] [Related]
18. Yohimbine protects against endotoxin-induced acute lung injury by blockade of alpha 2A adrenergic receptor in rats.
Lin Y; Zhu X; Yao WZ; Yang YL; A LT; Chen L
Chin Med J (Engl); 2011 Apr; 124(7):1069-74. PubMed ID: 21542970
[TBL] [Abstract][Full Text] [Related]
19. Dexmedetomidine preconditioning for myocardial protection in ischaemia-reperfusion injury in rats by downregulation of the high mobility group box 1-toll-like receptor 4-nuclear factor κB signalling pathway.
Yang YF; Peng K; Liu H; Meng XW; Zhang JJ; Ji FH
Clin Exp Pharmacol Physiol; 2017 Mar; 44(3):353-361. PubMed ID: 27998004
[TBL] [Abstract][Full Text] [Related]
20. Dexmedetomidine ameliorates acute lung injury following orthotopic autologous liver transplantation in rats probably by inhibiting Toll-like receptor 4-nuclear factor kappa B signaling.
Chi X; Wei X; Gao W; Guan J; Yu X; Wang Y; Li X; Cai J
J Transl Med; 2015 Jun; 13():190. PubMed ID: 26070954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]